You are here

Article Text

Article menu
Download PDFPDF
CORRESPONDENCE AND BRIEF REPORT
Prolonged survival among women with BRCA germline mutations and advanced endometrial cancer: a case series
  1. J. S. KWON*,
  2. J. LENEHAN†,
  3. M. CAREY‡ and
  4. P. AINSWORTH§
  1. *Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas
  2. †Schulich School of Medicine, University of Western Ontario, London, Ontario, Canada
  3. ‡Department of Systems Biology, MD Anderson Cancer Center, Houston, Texas
  4. §Department of Biochemistry, University of Western Ontario, Molecular Diagnostics Laboratory, London Health Sciences Centre, London, Ontario, Canada
  1. Address correspondence and reprint requests to: Janice S. Kwon, MD, MPH, Department of Gynecologic Oncology, MD Anderson Cancer Center, P.O. Box 301439, Houston, TX 77230–1439. Email: jskwon{at}mdanderson.org

Abstract

It is unclear if BRCA mutation carriers diagnosed with advanced endometrial cancer have a better prognosis compared to sporadic cases. From a population database of BRCA1 and 2 mutation carriers in Southwestern Ontario, Canada, we identified three women with advanced-stage endometrial cancer. They were 57, 59, and 64 years of age, and of English/Scottish, Ashkenazi Jewish, and English heritage, respectively. They had different mutations in BRCA1 (Q1240X:C3837T; 68_69delAG; 1961delA). One had a sarcomatoid carcinoma and two had uterine papillary serous carcinoma. All had stage IVB disease, with surgery followed by adjuvant chemotherapy and/or radiotherapy. Follow-up has ranged from 3.3 to 14.6 years. They are still alive and well with no evidence of recurrent disease. This observation raises the question as to whether BRCA mutations may be associated with a better prognosis in patients with advanced endometrial cancer

  • advanced endometrial cancer
  • BRCA
  • chemotherapy

http://dx.doi.org/10.1111/j.1525-1438.2007.01030.x

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    © 2007, IGCS and ESGO